Objective: To report the postoperative outcome of hepatectomy associated with portal vein resection (PVR) and to identify risk factors of clinical value for predicting postoperative liver failure and mortality. Summary Background Data: Resection of the portal vein during hepatectomy allows an increase in the number of patients who may benefit from a potentially curative operation that is, however, technically difficult and may increase postoperative morbidity and mortality. Few data are available about risk factors for liver failure and mortality after such extensive operations. Methods: Between July 1996 and July 2008, a total of 1348 patients were operated on for liver disease in our institution. Among them, 55 patients underwent liver resection associated with PVR. Medical records of these patients were prospectively collected and retrospectively analyzed. Results: Overall mortality for this selected group of patients was 7.2%. Irreversible liver failure was the main cause of death. Overall morbidity was 58.1%. A total of 94% of the patients (n = 52) underwent a major (≥ 3 segments) or an extended >4 segments) right or left hepatectomy. Univariate analysis showed that male gender (P = 0.004), extended liver resection (P = 0.028), and, particularly, extended right hepatectomy (P = 0.015) were significantly associated with an increased risk of postoperative liver failure. Male gender was the single independent risk factor for liver failure. Moreover, the presence of liver steatosis (P = 0.014), an extended right hepatectomy procedure (P = 0.047), and postoperative liver failure (P = 0.046) were significantly associated with an increased rate of postoperative mortality.
L iver resection is considered the standard treatment for primary liver tumor and colorectal liver metastases. [1] [2] [3] Major liver resections have been associated with an increased morbidity and mortality in comparison to more limited resections, particularly, when a chronic underlying liver disease is present. 4 Recent studies have shown that the volume of the remnant liver is correlated with perioperative morbidity and mortality. [5] [6] [7] Hepatobiliary cancers, such as hilar cholangiocarcinoma, bile duct and gallbladder carcinoma, and, less frequently, colorectal liver metastases may involve the portal vein bifurcation. Hepatocellular carcinoma is frequently associated with invasion of the portal vein, which is usually considered as a formal contraindication for liver transplantation. 8 Portal vein invasion and portal branch thrombosis induce ipsilateral liver atrophy and contralateral liver hypertrophy. Such patients often require major hepatic resection combined with resection of portal vein trunk (portal vein resection "PVR"). 3, 7, [9] [10] [11] [12] The resection of the portal vein trunk allows to increase the number of patients who may benefit from a potentially curative operation. However, it has been suggested that PVR is technically challenging and may increase postoperative morbidity and mortality. 13 Several series have reported an improved survival after combined liver resection and PVR, particularly for hilar cholangiocarcinoma. 3, 14, 15 Despite an increasing interest on such extended surgery, little is known about predictors of postoperative morbidity and mortality.
Few series have reported the perioperative outcome of major liver resection with PVR 3, [16] [17] [18] but none of them has focalized on predictors of postoperative liver failure (LF) and mortality.
The aim of the present study was to report the postoperative outcome of a large series of patients who underwent hepatectomy with PVR and to identify risk factors useful to predict LF and mortality.
PATIENTS AND METHODS
Between July 1996 and July 2008, a total of 1348 patients were operated on for liver disease in our institution. Among them, 55 (3.7%) patients underwent liver resection associated with PVR, constituting the study population. Liver resections were classified according to the Brisbane classification. 19 Major hepatectomy was defined as a resection of 3 or more liver segments, whereas extended hepatectomy was defined as a resection of more than 4 liver segments. The data of the patients were prospectively collected and retrospectively analyzed.
Definition of Surgical Mortality and Morbidity
Surgical mortality included intraoperative, within 30 days after surgery, or in-hospital deaths. All postoperative complications affecting the outcome or increasing the length of the hospital stay were recorded. LF was diagnosed according to the "50-50" Beaujon's criteria of LF on postoperative day 5 (serum bilirubin >50 μmol/L, and prothrombin time <50%). 20 The severity of each complications was classified according to Clavien's classification, reported in Dindo et al. 21 
Perioperative Management and Surgical Technique
Patients with obstructive jaundice requiring a major (≥3 segments) or an extended right hepatectomy (>4 segments) underwent preoperative percutaneous transhepatic biliary drainage. Liver resection was postponed until bilirubin level was less than 3 times the normal value. Patients with obstructive jaundice requiring a major or an extended left hepatectomy underwent liver resection without preoperative percutaneous transhepatic biliary drainage. Portal vein embolization (PVE) was performed in patients with a future remnant liver of less than 30%. Parenchymal transection was performed with the Cavitron Ultrasonic Surgical Aspirator without hepatic pedicle clamping. However, in case of bleeding during liver transection, the hepatic pedicle was clamped mainly by intermittent clamping (10 minutes of clamping and 5 minutes of clamping release). In all patients, the PVR was performed after completing the liver parenchyma transection and it was conducted under portal vein occlusion only, to preserve the arterial hepatic flow. In all cases, a segmental PVR was performed followed by a termino-terminal anastomosis with 6/0 nonabsorbable monofilament running sutures; a short "growth" factor (0.5-1 cm) was systematically used to avoid postoperative anastomosis stricture (Fig. 1, 2) 2 . An interposition graft was never used. Indeed, the right colon and the root of the mesentery were systematically mobilized to obtain a tension-free anastomosis between the portal branch of the remaining trunk. In patients undergoing bile duct resection, the biliary tract was reconstructed by an hepatico-jejunostomy using a Roux-en-Y loop with external biliary stenting. An abdominal drainage was systematically placed next to the liver transection area. The postoperative care was standardized as previously reported. 22 Briefly, after the hepatectomy, the patients were transferred to the intensive care unit. An artificial nutrition was started the day after surgery and consisted exclusively of total parenteral nutrition until the postoperative ileus resolved. Antibiotics were continued for 24 hours postoperatively. No systematic anticoagulation was used. Hepatic function and coagulation were monitored daily until postoperative day 7. All patients underwent an abdominal computed tomography scan before hospital discharge. 
Statistics
Results are expressed as mean ± standard error of mean. Fisher exact test, χ 2 and Mann-Whitney tests were used. Risk factors for overall morbidity and LF were determined by a logistic regression model. A difference was considered significant when the P value was less than 0.05. All statistical calculations were performed with the computer software package Statview (Abacus Concepts Inc., Berkeley, Calif).
RESULTS

Patients Characteristics and Perioperative Data
The patients were 24 males and 31 females. Their mean age was 63.0 ± 11 . The American Society of Anesthesiologists score was 1 or 2 in 47 patients and 3 in 8 patients. The indications for liver resection were hilar cholangiocarcinoma in 28 patients, colorectal liver metastases in 11, gallbladder carcinoma in 6, intrahepatic cholangiocarcinoma in 6, hepatocellular carcinoma in 2, biliary stenosis after bile duct injury during laparoscopic cholecystectomy in 1, and liver metastases secondary to gastric adenocarcinoma in 1 patient. Preoperative biliary drainage was performed in 23 patients. Fifteen patients underwent PVE: 9 patients with hilar cholangiocarcinoma, 2 before a (normal value 1.7-21). Preoperative mean total prothrombin rate was 88.6% ± 17.0% (54.0%-129.0%) (normal value >70%). The size of the largest tumor was 52.0 ± 50.2 mm (5-270 mm). Patients' characteristics were reported in Table 1 . Four patients with colorectal liver metastases received neoadjuvant chemotherapy. In 3 patients with colorectal liver metastases the major or extended hepatectomy was a rehepatectomy. At the final pathology, 36% of the patients had liver steatosis in particular, liver steatosis was detected in 11 patients who underwent an extended right hepatectomy.
Perioperative Data
The type of hepatectomy performed is reported in Table 2 . Among the 26 patients who underwent an extended right hepatectomy, 12 received a preoperative PVE. The mean operative time was 409 ± 92 minutes (range, 270-645). Thirty-two patients (58%) required blood cell transfusion intraoperativelly. The mean amount of blood cell transfusion was 4.1 ± 2.5 units (range, 2-13). During the postoperative period 13 patients received further blood cell transfusions. The mean amount of blood cell transfusion was 6.6 ± 6.9 units (range, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Liver parenchyma transection was performed without hepatic pedicle clamping in 28 patients, under intermittent hepatic pedicle clamping in 20 patients and under continuous hepatic pedicle clamping in 7 patients. The mean total time of hepatic pedicle clamping was 36.3 ± 21.4 minutes (range, 10-110 minutes). The mean clamping time required to perform the PVR was 18.9 ± 4.9 minutes (range, 10-35 minutes). All patients underwent a segmental resection of the portal vein without interposition graft. The mean length of portal vein resected was 2 cm (range, 1-4 cm). Portal vein reconstruction was achieved in 15 patients by end-to-end anastomosis between the right portal branch and the remaining trunk, and in 40 patients by end-to-end anastomosis between the left portal branch and the remaining trunk.
Associated Procedures
Associated procedures at the time of hepatectomy were performed in 51 patients. They included hepatic pedicle and retroduodenopancreatic lymph node dissection in 49 patients, extrahepatic bile duct resection in 19, pancreaticoduodenectomy in 3, primary colonic tumor resection in 1, and resection of peritoneal carcinomatosis in 3. Several patients underwent multiple associated procedures.
Postoperative Outcome
Mortality
Overall mortality was 7.2% (n = 4), the mortality after extended right hepatectomy was 15.3%. Four patients died at 19, 37, 39, and 60 days, respectively. These patients underwent an extended right hepatectomy and developed postoperative LF. The cause of death was irreversible LF in 3 patients and sepsis due to leakage from a jejuno-jejunal anastomosis in 1. Three patients had an hilar cholangiocarcinoma and 1 had colorectal liver metastases. Among the 4 patients, all had preoperative right PVE. During the same study period, 326 major or extended right or left hepatectomy without PVR have been performed in our institution. The overall postoperative mortality was 3.5%, the mortality rates for extended right and extended left hepatectomy were 9.3% and 0%, respectively. Postoperative LF occurred in 10.5% of the patients.
Morbidity
Overall morbidity was 58.1% (32/55). In 32 patients 47 complications occurred. Their grading, according to Clavien's classification, reported in Dindo et al, 21 is reported in Table 3 . Among them, 19 patients developed a single complication, 11 had 2 complications, and 2 patients had 3 complications. None of the patients had postoperative portal vein thrombosis. Six patients required 7 relaparotomies; the indications for relaparotomy were hemorrhage (n = 2), biliary leak (n = 1), stenosis of the biliodigestive anastomosis (n = 1), colonic fistula (n = 1), leakage from the jejuno-jejunal anastomosis (n = 1) and abdominal wall dehiscence (n = 1). Fourteen patients had postoperative LF. Overall morbidity was similar for patients who underwent or not an extended right hepatectomy (57.6% versus 61.5%, respectively; P = 1.00).
Risk Factors for Mortality
Age, gender, ASA score, preoperative percutaneous external biliary drainage, preoperative bilirubin blood level, perioperative blood transfusion, extended liver resection, relaparotomy, PVE, hepatic pedicle clamping, hepatic parenchyma fibrosis, and associated procedure did not affect the occurrence of postoperative mortality. However, liver steatosis (P = 0.014), extended right hepatectomy procedure (P = 0.047), and the occurrence of LF (P = 0.046) were significantly associated with postoperative mortality (Table 4) . 
Risk Factors for LF
Univariate analysis showed that male gender (P = 0.004), extended liver resection (P = 0.028), and particularly extended right hepatectomy (P = 0.015), were significantly associated with an increased risk of postoperative LF. All the other remaining factors analyzed were not significantly associated with postoperative LF (Table 5 ). Multivariate analysis showed that male gender was the only independent factor associated with postoperative LF (odds ratio 
DISCUSSION
The present study showed that the postoperative outcome of patients who underwent hepatic resection with resection of portal vein trunk (PVR) was similar to that reported for patients undergoing liver resection without PVR. However, extended liver resection (>4 segments), liver steatosis, and postoperative LF increased the risk of mortality. The type of liver resection and the male gender showed to be risk factors for LF.
Balzan et al showed a significant correlation between the occurrence of LF and mortality after liver resection. 20 The present series confirmed that LF was the main cause of death after extended hepatectomy with PVR. Moreover, the 50-50 criteria for LF on postoperative day 5 proved to be a clinically relevant definition allowing an early postoperative identification of the patients at high risk for mortality. PVE was proposed to induce liver hypertrophy of the future remnant liver (FRL) in patients who need major hepatectomy to reduce postoperative liver dysfunction and fatal LF. 24 Currently, PVE is considered as the standard adjuvant treatment before liver resection for patient with too small FRL volume. 3, [25] [26] [27] In the present series, almost 50% of the patients who underwent an extended right hepatectomy received a PVE to optimize liver volume and hepatic function as a preparation before liver surgery. However, lethal LF still occurred in 4 patients. Such results underline the fact that the volume of the FRL is only one among the factors which should be considered before hepatectomy to avoid LF. The male gender, and the extent of the liver resection are others.
Male gender is increasingly recognized as a major deleterious risk factor influencing the outcome of patients suffering from trauma or sepsis. 28, 29 Sex hormones, in fact, modulate the immune and cardiovascular responses to trauma. [28] [29] [30] Major hepatectomy with PVR may be considered as a "planned" major trauma for the patients. Interestingly, in the present series, male gender appeared to be an independent risk factor for postoperative LF.
Liver steatosis is the most common histologic finding in liver biopsy. About 20% of patients planned for liver resection have some degree of steatosis 4, 31, 32 Steatosis has been associated with an increased postoperative morbidity and mortality. 4, 31, 32 Recently, McCormack et al 32 showed that the presence of liver steatosis per se regardless of the quantitative (mild, moderate, severe) and qualitative (microsteatosis, macrostatosis) type was the most significant risk factor for postoperative complications after major hepatectomy. Thirtysix percent of our patients had liver steatosis mainly in the group of patients requiring an extended hepatectomy. Similarly reported in previous studies, steatosis was a risk factor for mortality in our series also. Recently, plain computed tomography and chemical-shift magnetic resonance imaging were proposed as useful and non invasive alternative to liver biopsies to evaluate liver steatosis preoperatively. 33 However, there is still little evidence that those methods are more useful than to preoperative liver biopsies. 34 Therefore; it seems advisable to perform a preoperative liver biopsy to assess the presence of liver steatosis before undergoing liver resection in patients requiring PVR. Extended right hepatectomy with PVR should be avoided in patients with liver steatosis. According to the most recent advances in the understanding of liver steatosis it seems that such condition might be ameliorated by specific treatment. 35, 36 Further studies should demonstrate that such treatments are associated with a reduction of postoperative mortality in patients requiring extended right hepatectomy with PVR.
Ebata et al 18 reported in 2003 a series of 52 hepatectomies combined with PVR for hilar cholangiocarcinoma; the postoperative mortality was 9.6%, because of LF and/or multiple organ failure. Few years later, the same authors 3 analyzed the surgical outcome of 240 patients who underwent PVE before extended hepatectomy for biliary cancer. Among the 193 patients who were finally resected 63 underwent liver resection combined with PVR. The overall mortality in this subgroup was 15.8% (10/63). In particular, all exept 1 patient underwent a right or an extended right hepatectomy with PVR. In our present study overall mortality was 7.2% whereas mortality after extended right hepatectomy was 15.3%. Interestingly, in our series, extended right hepatectomy, liver steatosis, and postoperative LF were shown to be risk factors for mortality. The postoperative mortality after major liver resection in high volume center is currently between 2% and 5%. 1, 4 However, extended right hepatectomy with PVR is still associated with an high postoperative mortality between 12% and 40% (Table 6) . 3, 13, [37] [38] [39] On the contrary, mortality was nil for left or extended left hepatectomy. Therefore, liver resection should be as limited as possible on the right side in patients requiring PVR, and left or extended left hepatectomy should be preferred whenever possible.
Extrahepatic procedures at the time of liver resection have been associated with an increased postoperative mortality. 4 In the present study, the association of an extrahepatic procedure to liver resection, was not associated with an increased postoperative mortality rate. However, it should be underlined that the majority of the patients (92.7%) underwent an associated procedure limiting the value of the statistical analysis. Therefore, associated procedures should still be carefully evaluated in patients requiring liver resection with PVR.
Postoperative portal vein thrombosis is a severe complication occurring in 2% to 9% 40, 41 of patients requiring PVR/reconstruction leading to LF and death in most of the cases. Interestingly, in the present long series, none of the patients had postoperative portal vein thrombosis. Indeed, it is our policy to avoid interposition graft whenever possible, due to the high risk of postoperative thrombosis, 42 by extensive mobilization of the right colon and of the root of the mesentery in view to obtain enough "length" to perform a direct tension-free anastomosis. PVR and anastomosis was systematically performed at the end of the liver transection allowing for a short portal vein clamping. Moreover, the removal of the specimen allowed to obtain a further mobilization of the remaining liver to facilitate the vascular anastomosis.
In conclusion, the present study confirms that liver resection with PVR can be performed with acceptable overall morbidity and mortality rates. Preoperative selection of the patients should take in consideration the gender and the extent and the side of hepatic resections to avoid irreversible postoperative LF and to reduce postoperative mortality.
